BioSpace News Archive

Lexaria Bioscience Corp. is pleased to provide this annual letter from CEO Chris Bunka as a strategic update to all stakeholders.

Digital healthcare innovator Wellysis is making waves in the global market with its revolutionary electrocardiogram monitoring solution, ‘S-Patch,’ securing strategic partnerships and distribution deals to propel its entry into the lucrative US and Indian markets.

Ocutrx Technologies, Inc. proudly announces the latest development of its ORLenz™ headset.

ZetrOZ Systems, inventor of sustained acoustic medicine, will demonstrate its sam® X1 wearable ultrasound unit for physicians and other healthcare providers at The Las Vegas Regenerative Medicine and MSK Ultrasound Course, January 25-27, at the Sahara Hotel.

Boncha Bio has recently published a comprehensive White Paper , introducing ‘Candyceutical’ - a revolutionary, all-in-one solution in the health supplements industry.

Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.

XVIVO Perfusion AB In a recently published clinical trial conducted by the UMCG in Groningen, the Netherlands, XVIVO’s Liver Assist has demonstrated its potential to reshape liver transplant logistics.

Eurofins Genomics, a global leader in sequencing services, announces the opening of a new, certified sequencing lab in Bothell, Washington, serving the greater Seattle area.

OrphAI Therapeutics Inc. announced the appointment of Jay S. Fine, Ph.D. to its Board of Directors.

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, and Translational Genomics Research Institute, a precision medicine research organization that is part of City of Hope, have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.